The Diabetes Transition of Hospital Care (DiaTOHC) Pilot Study: A Randomized Controlled Trial of an Intervention Designed to Reduce Readmission Risk of Adults with Diabetes
dc.contributor.author | Rubin, DJ | |
dc.contributor.author | Gogineni, P | |
dc.contributor.author | Deak, A | |
dc.contributor.author | Vaz, C | |
dc.contributor.author | Watts, S | |
dc.contributor.author | Recco, D | |
dc.contributor.author | Dillard, F | |
dc.contributor.author | Wu, J | |
dc.contributor.author | Karunakaran, A | |
dc.contributor.author | Kondamuri, N | |
dc.contributor.author | Zhao, H | |
dc.contributor.author | Naylor, MD | |
dc.contributor.author | Golden, SH | |
dc.contributor.author | Allen, S | |
dc.coverage.spatial | Switzerland | |
dc.date.accessioned | 2022-12-22T20:39:34Z | |
dc.date.available | 2022-12-22T20:39:34Z | |
dc.date.issued | 2022-03-01 | |
dc.identifier.issn | 2077-0383 | |
dc.identifier.issn | 2077-0383 | |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pubmed/35329797 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/175296 | en |
dc.description.abstract | Hospital readmission within 30 days of discharge (30-day readmission) is a high-priority quality measure and cost target. The purpose of this study was to explore the feasibility and efficacy of the Diabetes Transition of Hospital Care (DiaTOHC) Program on readmission risk in high-risk adults with diabetes. This was a non-blinded pilot randomized controlled trial (RCT) that compared usual care (UC) to DiaTOHC at a safety-net hospital. The primary outcome was all-cause 30-day readmission. Between 16 October 2017 and 30 May 2019, 93 patients were randomized. In the intention-to-treat (ITT) population, 14 (31.1%) of 45 DiaTOHC subjects and 15 (32.6%) of 46 UC subjects had a 30-day readmission, while 35.6% DiaTOHC and 39.1% UC subjects had a 30-day readmission or ED visit. The Intervention–UC cost ratio was 0.33 (0.13–0.79) 95%CI. At least 93% of subjects were satisfied with key intervention components. Among the 69 subjects with baseline HbA1c >7.0% (53 mmol/mol), 30-day readmission rates were 23.5% (DiaTOHC) and 31.4% (UC) and composite 30-day readmission/ED visit rates were 26.5% (DiaTOHC) and 40.0% (UC). In this subgroup, the Intervention–UC cost ratio was 0.21 (0.08–0.58) 95%CI. The DiaTOHC Program may be feasible and may decrease combined 30-day readmission/ED visit risk as well as healthcare costs among patients with HbA1c levels >7.0% (53 mmol/mol). | |
dc.format.medium | Electronic | |
dc.language | eng | |
dc.publisher | MDPI | |
dc.rights | Licence for published version: Creative Commons Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | pilot study | |
dc.subject | prospective randomized trial | |
dc.subject | rehospitalization | |
dc.subject | transition care | |
dc.title | The Diabetes Transition of Hospital Care (DiaTOHC) Pilot Study: A Randomized Controlled Trial of an Intervention Designed to Reduce Readmission Risk of Adults with Diabetes | |
dc.type | Article | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/175296/2/The Diabetes Transition of Hospital Care (DiaTOHC) Pilot Study A Randomized Controlled Trial of an Intervention Designed to .pdf | |
dc.identifier.doi | 10.3390/jcm11061471 | |
dc.identifier.doi | https://dx.doi.org/10.7302/6677 | |
dc.identifier.source | Journal of Clinical Medicine | |
dc.description.version | Published version | |
dc.date.updated | 2022-12-22T20:39:30Z | |
dc.identifier.orcid | 0000-0002-0327-5590 | |
dc.identifier.volume | 11 | |
dc.identifier.issue | 6 | |
dc.identifier.startpage | 1471 | |
dc.identifier.name-orcid | Rubin, DJ | |
dc.identifier.name-orcid | Gogineni, P; 0000-0002-0327-5590 | |
dc.identifier.name-orcid | Deak, A | |
dc.identifier.name-orcid | Vaz, C | |
dc.identifier.name-orcid | Watts, S | |
dc.identifier.name-orcid | Recco, D | |
dc.identifier.name-orcid | Dillard, F | |
dc.identifier.name-orcid | Wu, J | |
dc.identifier.name-orcid | Karunakaran, A | |
dc.identifier.name-orcid | Kondamuri, N | |
dc.identifier.name-orcid | Zhao, H | |
dc.identifier.name-orcid | Naylor, MD | |
dc.identifier.name-orcid | Golden, SH | |
dc.identifier.name-orcid | Allen, S | |
dc.working.doi | 10.7302/6677 | en |
dc.owningcollname | Internal Medicine, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.